Results 11 to 20 of about 3,945 (173)

The low-density lipoprotein receptor and apolipoprotein E associated with CCHFV particles mediate CCHFV entry into cells [PDF]

open access: yesNature Communications
The Crimean-Congo hemorrhagic fever virus (CCHFV) is an emerging pathogen of the Orthonairovirus genus that can cause severe and often lethal hemorrhagic diseases in humans. CCHFV has a broad tropism and can infect a variety of species and tissues. Here,
Maureen Ritter   +17 more
doaj   +2 more sources

Multiple Reassortments, Limited Geographic Spread, and Comparable Pathogenicity of Crimean-Congo Hemorrhagic Fever Viruses in Sivas Province, Türkiye. [PDF]

open access: yesJ Med Virol
ABSTRACT Crimean‐Congo hemorrhagic fever virus (CCHFV) is a segmented RNA virus that can cause severe hemorrhagic fever and is primarily transmitted to humans and other mammals through tick bites. Since segment reassortment can increase genetic diversity and disease severity, we sampled infected ticks and humans in Sivas Province, Türkiye, a region ...
Lin Q   +15 more
europepmc   +2 more sources

Crimean-Congo Haemorrhagic Fever Virus Exposure in Horses and Donkeys in Border Livestock Markets of Nigeria. [PDF]

open access: yesZoonoses Public Health
ABSTRACT Introduction Crimean‐Congo haemorrhagic fever virus (CCHFV) is a tick‐borne zoonotic pathogen of major public health importance in Africa. Although CCHFV exposure has been reported in several livestock species in Nigeria, data on equids remain limited despite their extensive involvement in livestock movement and trade.
Ehizibolo DO   +14 more
europepmc   +2 more sources

NUCLEOSIDE-MODIFIED MRNA VACCINES PROTECT IFNAR -/- MICE AGAINST CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS INFECTION

open access: yesInternational Journal of Infectious Diseases, 2023
Intro: Crimean-Congo hemorrhagic fever orthonairovirus (CCHFV), is the causative agent of Crimean-Congo hemorrhagic fever (CCHF). Occurrence of the virus coincides with the distribution of its primary vector and reservoir, Hyalomma ticks.
A. Mirazimi
doaj   +1 more source

GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus

open access: yesnpj Vaccines, 2023
Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is a tick-borne virus that causes severe hemorrhagic disease in humans. There is a great need for effective vaccines and therapeutics against CCHFV for humans, as none are currently internationally approved ...
Gabrielle Scher   +4 more
doaj   +1 more source

Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
Crimean-Congo hemorrhagic fever virus (CCHFV) can cause severe hemorrhagic fever in humans and is mainly transmitted by ticks. There is no effective vaccine for Crimean-Congo hemorrhagic fever (CCHF) at present.
Yong-Liang Hu   +15 more
doaj   +1 more source

Purification of Crimean–Congo hemorrhagic fever virus nucleoprotein and its utility for serological diagnosis

open access: yesScientific Reports, 2021
Crimean–Congo hemorrhagic fever virus (CCHFV) causes a zoonotic disease, Crimean–Congo hemorrhagic fever (CCHF) endemic in Africa, Asia, the Middle East, and Southeastern Europe.
Boniface Pongombo Lombe   +16 more
doaj   +1 more source

CCHFV-related viruses (Family Bunyaviridae).

open access: yes, 2022
CCHFV-related viruses (Family Bunyaviridae).
Greg Smith (343139)   +5 more
core   +1 more source

Crimean–Congo Hemorrhagic Fever Virus Survey in Humans, Ticks, and Livestock in Agnam (Northeastern Senegal) from February 2021 to March 2022

open access: yesTropical Medicine and Infectious Disease, 2022
Crimean–Congo hemorrhagic fever virus (CCHFV) is widespread in Asia, Europe, and Africa. In Senegal, sporadic cases of CCHFV have been reported since 1960.
Moufid Mhamadi   +24 more
doaj   +1 more source

CCHF Viral RNA, anti-CCHFV IgM and anti-CCHFV IgG kinetics of CCHFV cases.

open access: yes, 2021
(A) CCHF viral RNA amongst fatal and survivors (B) CCHF viral RNA amongst individual survivors at different time points (C) Anti-CCHFV-IgM antibodies amongst individual survivors at different time points and fatal cases (D) Anti-CCHFV-IgG antibodies ...
Himanshu Kaushal (558851)   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy